Analyst Price Targets — DOCS
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| May 14, 2026 8:45 pm | — | Barclays | $20.00 | $18.01 | TheFly | Doximity downgraded to Equal Weight from Overweight at Barclays |
| May 14, 2026 1:21 pm | Jailendra Singh | Truist Financial | $19.00 | $17.87 | TheFly | Doximity price target lowered to $19 from $29 at Truist |
| May 14, 2026 11:42 am | Sean Dodge | BMO Capital | $20.00 | $23.39 | TheFly | Doximity price target lowered to $20 from $25 at BMO Capital |
| May 14, 2026 11:19 am | Scott Berg | Needham | $27.00 | $23.39 | TheFly | Doximity price target lowered to $27 from $55 at Needham |
| May 14, 2026 11:16 am | — | Mizuho Securities | $26.00 | $23.39 | TheFly | Doximity price target lowered to $26 from $34 at Mizuho |
| May 14, 2026 11:01 am | — | Canaccord Genuity | $30.00 | $23.39 | TheFly | Doximity price target lowered to $30 from $34 at Canaccord |
| May 14, 2026 10:52 am | — | Goldman Sachs | $24.00 | $23.39 | TheFly | Doximity price target lowered to $24 from $28 at Goldman Sachs |
| May 14, 2026 10:35 am | Craig Hettenbach | Morgan Stanley | $35.00 | $23.39 | TheFly | Doximity price target lowered to $35 from $49 at Morgan Stanley |
| May 14, 2026 10:12 am | Michael Cherny | Leerink Partners | $25.00 | $23.39 | TheFly | Doximity price target lowered to $25 from $31 at Leerink |
| May 14, 2026 8:51 am | — | Wells Fargo | $18.00 | $23.39 | TheFly | Doximity downgraded to Equal Weight from Overweight at Wells Fargo |
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for DOCS

Doximity (DOCS) closed at $21.52 in the latest trading session, marking a -3.11% move from the prior day.

DOCS is ramping up AI across physician workflows and enterprise tools, but weak pharma ads and higher AI spending may test near-term growth.

SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal first quarter ended June 30, 2026 after market close on August 6, 2026. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results. To listen to a live audio webcast, please visit…

SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that Doximity Ask, its HIPAA-compliant clinical AI platform, outperformed leading frontier AI models in the NOHARM (Numerous Options Harm Assessment for Risk in Medicine) benchmark, one of the most comprehensive independent evaluations of clinical AI safety to date. The study,…

In the closing of the recent trading day, Doximity (DOCS) stood at $21.77, denoting a -1.09% move from the preceding trading day.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for DOCS.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
